NLS Pharmaceutics Ltd. announced that it will receive $1,750,000 in funding on March 20, 2024. The company will issue common shares and warrants in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1393 USD | -1.55% | +0.94% | -76.39% |
08/04 | Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors | CI |
03/04 | NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-76.39% | 6.57M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- NLSP Stock
- News NLS Pharmaceutics Ltd.
- NLS Pharmaceutics Ltd. announced that it expects to receive $1.75 million in funding